Takeda Pharmaceuticals U.S.A., Inc.

Lawsuit Filings

Takeda, Par, Watson, Amneal Conspired to Suppress Competition for Generic Gout Treatment, Class Action Claims

August 9, 2021 Another class action alleges Takeda and Par have conspired to suppress competition in the generic drug market, this time for Colcrys (colchicine).

Pay-for-Delay: Antitrust Class Action Claims Takeda Paid to Keep Generic IBS Drug Off the Market

July 1, 2021 A class action alleges Takeda and Par violated antitrust law when the two struck an agreement to keep the latter’s generic version of Amitiza off the market for up to six years.